*In a real-world private practice setting-200 patients (400 eyes).
?At 3 months post-op; n = 212 eyes
?At 3 months post-op; n=60 eyes
§In 6.0 mm pupils, mean ± SD spherical aberration decreased by 0.07μm after wavelight plus (0.13 ± 0.10 preop; 0.06 ± 0.12 at 3 months postop) and increased by 0.06μm after wavefront-optimized treatment (0.12 ± 0.10 pre-op; 0.18 ± 0.12 at 3 months postop); p<0,001 for wavelight plus vs. wavefront-optimized.
InnovEyes? Sightmap Diagnostic Device User Manual 1089
Mrochen M, Bueler M,Donitzky C, Seiler T. Optical rcay tracing for the calculation of optimized corneal ablation profiles in refractive treatment planning. J Refract Surg. 2008;24:S446-S451.
Simon D et al. Ray Tracing: the Future of Refractive Surgery. Cataract & Refractive Surgery Today Europe. August 2011
Kanellopoulos AJ. Initial Outcomes with Customized Myopic LASIK, Guided by Automated Ray Tracing Optimization: A Novel Technique. Clin Ophthalmol. 2020;14:3955-3963.
Cummings A, Kelly G. Optical ray tracing-guided myopic laser in situ keratomileusis: 1-year clinical outcomes. Clin Ophthalmol. 2013:7 1181-1191.
Khoramnia R, Naujokaitis T, Bl?ck L, et al. Prospective intraindividual comparison of automated customized ray-tracing-guided vs wavefront-optimized laser in situ keratomileusis. Ophthalmology. 2025.
Kanellopoulos AJ, Maus M, Bala C, et al. International Multicenter, Myopic and Myopic Astigmatism Femto LASIK, Customized by Automated Ray-Tracing Ablation Profile Calculation: A Post market Study. Clin Ophthalmol. 2024;18:525-536.
Bueler M & Mrochen M, inventors; Computer program for ophthalmological surgery. U.S. Patent No. 2,008,033,408. 2008
He G, Bala C. Ray-tracing-guided myopic LASIK: real-world clinical outcomes. J Cataract Refract Surg. 2023 Nov 1;49(11):1140-1146.
Ting Liu et al. Visual and optical quality outcomes of SMILE and FS-LASIK for myopia in the very early phase after surgery. BMC Ophthalmology. 2019;19:88.
Schumacher S, Seiler T, Cummings A, Maus M & Mrochen M. Optical ray tracing-guided laser in situ keratomileusis for moderate to high myopic astigmatism. J Cataract Refract Surg. 2012;38:28-34